Htay Htay Han
Clover Biopharmaceuticals (China)(CN)
Publications by Year
Research Areas
Viral gastroenteritis research and epidemiology, Viral Infections and Immunology Research, Hepatitis Viruses Studies and Epidemiology, SARS-CoV-2 and COVID-19 Research, Bacterial Infections and Vaccines
Most-Cited Works
- → Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants(2010)908 cited
- → Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial(2021)280 cited
- → Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial(2012)140 cited
- → Evaluation of RIX4414, A Live, Attenuated Rotavirus Vaccine, in a Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Trial Involving 2464 Singaporean Infants(2005)126 cited
- → Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial(2022)113 cited
- → Live Attenuated Human Rotavirus Vaccine, RIX4414, Provides Clinical Protection in Infants Against Rotavirus Strains With and Without Shared G and P Genotypes(2009)79 cited
- → Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life(2011)78 cited
- → Horizontal transmission of a human rotavirus vaccine strain—A randomized, placebo-controlled study in twins(2011)78 cited
- → Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants(2009)71 cited
- → Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa(2010)66 cited